Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:12 AM
Ignite Modification Date:
2025-12-25 @ 2:12 AM
NCT ID:
NCT00863460
Eligibility Criteria:
Inclusion Criteria:
* Histopathologically or cytologically proven diagnostic of Primary CNS lymphoma
* All histological types of non-Hodgkin's lymphoma, except MALT
* Age \> 18 and \< 60 ans.
* Negative for HIV, HCV and HBV
* Written informed consent -
Exclusion Criteria:
* Age \< 18 or \> 60 ans
* Isolated intra-ocular lymphoma
* Previous history of indolent lymphoma
* Previous chemotherapy or radiotherapy for PCNSL
* Isolated CNS relapse of systemic NHL
* Previous history of cancer in the last 5 years, except basocellular carcinoma and non invasive cervix cancer
* Renal insufficiency or creatinin clearance \< 60 ml/min
* Liver enzymes \> 3N.
* Platelets \< 100 000/mm3 or neutrophils \< 1500/mm3)
* Previous history of organ transplantation or other cause of severe immunodeficiency
* Pregnancy or active sexual women with no contraception
* Unable to follow the protocol for any reason
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT00863460
Study Brief:
Protocol Section:
NCT00863460